AstraZeneca Investing $300 Million into New Cutting-Edge Cell Therapy Facility in Maryland February 6, 2024 In a recent press release, Governor Wes Moore announced a groundbreaking initiative that positions Maryland [….]
Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca at 700 Progress Way in Gaithersburg, MD
Published on :Matan Companies Signs 198,000 SF Full-Building Lease with AstraZeneca at 700 Progress Way in Gaithersburg, MD
When It Comes to Biomanufacturing in Maryland – It’s All About the People
Published on :When It Comes to Biomanufacturing in Maryland – It’s All About the People The Biohealth Capital Region Forum held a panel on the State of Biomanufacturing in which representatives from [….]
Spatial Biology Symposium
Published on :This exceptional in-person Spatial Biology event consists of a two-day symposium and a one-day hands-on in silico based laboratory workshop. The symposium features esteemed experts from pathology, spatial biology, multiplex [….]
Weekly Quick Hits (Greater Philly) – Week of May 15, 2023
Published on :Weekly Quick Hits (Greater Philly) – Week of May 15, 2023 By Mark TerryMay 19, 2023 Funding, Awards and Collaborations Soligenix Q1: Recent IPO Raised $8.5 Million Plus Positive HyBryte [….]
SERB Pharma Inks Licensing Deal with SFJ for Brilinta Reversal Agent
Published on :SERB Pharma Inks Licensing Deal with SFJ for Brilinta Reversal Agent By Mark TerryMay 12, 2023 Philadelphia-based SERB Pharmaceuticals has inked a licensing deal with San Francisco’s SFJ Pharmaceuticals for [….]
MilliporeSigma’s Curiosity Cube Rolls Into Maryland, Bringing Hands-on Learning Opps to Local Students
Published on :MilliporeSigma’s Curiosity Cube Rolls Into Maryland, Bringing Hands-on Learning Opps to Local Students By Alex Keown and Sarah EllinwoodMay 9, 2023 If you’re a scientist, chances are growing up you [….]
Mineralys and the Second Renaissance of Hypertension Research
Published on :Mineralys and the Second Renaissance of Hypertension Research By Mark TerryMay 5, 2023 Mineralys Therapeutics, headquartered in Radnor, Pa., dosed the first patient in its ADVANCE-HTN pivotal trial of lorundrostat [….]
Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio
Published on :Astellas Buys Iveric Bio for $5.9 Billion to Bolster Ophthalmology Portfolio By Mark TerryMay 2, 2023 Tokyo-based Astellas Pharma is buying Parsippany, NJ’s Iveric Bio for $5.9 billion. Iveric Bio [….]
Weekly Quick Hits (Greater Philly) – Week of April 24, 2023
Published on :Weekly Quick Hits (Greater Philly) – Week of April 24, 2023 By Mark Terry, Alex Keown, and Sarah EllinwoodApril 28, 2023 Funding, Awards and Collaborations The Innovation Space Joins Delaware [….]